BioNTech
NEWS
The WHO’s Emergency Use Listing (EUL), a prerequisite for COVAX Facility vaccine supply, evaluates the safety, quality, and efficacy of the COVID-19 vaccines. As such, today’s approval allows the vaccine to be used by agencies and NGOs around the world.
Biopharma and life sciences companies from across the globe provide updates on their pipelines and businesses.
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for February 2, 2021.
Overall, against moderate-severe COVID-19 infection, the vaccine was 72% effective 28 days after vaccination in the U.S., 66% in hard-hit Latin America, and bottomed out at 57% in South Africa.
The pharmaceutical industry continues to demonstrate its willingness to team up in the ongoing combat against the global COVID-19 pandemic.
The data is continuing to come in on the various COVID-19 variants, and so far the news is pretty good.
Much of the attention on Pfizer, BioNTech, Moderna, Johnson & Johnson and AstraZeneca for the last few months has been on their COVID-19 vaccine efforts.
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for January 26, 2021.
Every week there are numerous scientific studies published. Here’s a look at some of the more interesting ones.
JOBS
IN THE PRESS